Mark Cuban argues the U.S. healthcare debate overlooks a fundamental issue. The real challenge isn’t choosing between government or private control—it’s the absence of price transparency.
“I’m not against single-payer or universal healthcare,” Cuban told KFF Health News on August 18. “But without knowing all the costs, without transparency, you can’t determine if it’s a better solution.”
Transparency as the missing piece
The billionaire entrepreneur and former Dallas Mavericks owner has long advocated for clearer pricing in healthcare. His venture, Mark Cuban Cost Plus Drugs, began in 2022 to sell generic medications at a fixed 15% markup, displaying all costs upfront. This model challenges traditional pharmacies and insurance plans, which frequently hide their pricing structures.
“Others set prices based on what the market will bear; we set them based on what we consider fair,” he explained. The approach has pressured competitors to justify their own pricing or clarify differences.
Cuban’s stance isn’t tied to ideology. He believes transparency rules should apply whether the system is government-run or managed by private insurers. Without visibility into contract terms, he said, “negotiating better deals becomes impossible.”
Related: NAD+ Supplement Slows Muscle Aging Markers
The lack of clarity extends beyond prescription drugs. Cuban highlighted nonemergency medical services, where patients often face vastly different prices for identical procedures. He proposed a straightforward change: count every medical purchase toward insurance deductibles and out-of-pocket limits, which isn’t standard practice today. This adjustment would encourage consumers to compare prices and push providers to compete.
Most patients remain unaware of how healthcare pricing operates. Hospitals and insurers negotiate rates in secret, and bills often arrive with confusing charges unrelated to actual costs. The system functions like a black box, leaving patients in the dark until after treatment.
Breaking up the giants
Cuban also criticized the increasing consolidation in healthcare. Corporations like UnitedHealth Group and CVS Health now control insurers, pharmacies, and care providers, forming integrated networks that dominate every stage of the process. “If you split these massive conglomerates, prices would drop immediately,” he stated.
Lawmakers have largely ignored this approach. Cuban pointed to the Break Up Big Medicine Act, introduced by Republican Josh Hawley and Democrat Elizabeth Warren, as one of the few bipartisan efforts addressing the problem. The legislation would strengthen federal regulators’ ability to block healthcare mergers.
The proposal faces significant opposition. Healthcare lobbying groups hold considerable influence in Washington, and many lawmakers depend on their financial backing. Cuban’s own company, Cost Plus Drugs, has made inroads but remains a minor player in a market dominated by a few powerful entities.
He described the issue as a matter of trust. “Trust equals transparency divided by self-interest,” Cuban said. Currently, the formula fails. Patients distrust insurers, insurers distrust providers, and providers question whether they’ll be paid fairly. Restoring confidence, he argued, requires forcing every part of the system to disclose its pricing.
Progressives push for Medicare for All
Cuban’s remarks coincided with recent primary victories by progressive candidates, including Abdul El-Sayed, who secured the Democratic Senate nomination in Michigan. El-Sayed supports Medicare for All, a single-payer system that would replace private insurance with government coverage.
But Cuban insisted the debate over who pays for healthcare comes second to understanding its true cost. “Whether the government or private companies handle negotiations, without knowing how deals are structured, improving them is impossible,” he said.
The discussion was part of KFF Health News’ “How Would You Fix It?” series, led by chief Washington correspondent Julie Rovner. A condensed version aired on August 20 on the What the Health? podcast.
The U.S. healthcare system continues to operate with hidden fees and opaque pricing. Cuban’s solution is straightforward: make all costs public and let the market—or the government—determine the rest.
Efforts to reshape public health policy often focus on broader systemic changes, but transparency remains a critical first step. For example, new leadership in Louisiana has prioritized clear communication about healthcare costs as part of its strategy.
